fashion -WSS

fashion

author：explore 2025-09-27 22:48:20 - browse：29146

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

entertainment

WSS

Obesity drug from Roche shows promise in early study

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Letters to First Opinion on caregivers, digital health, and more

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Abbott's new stent may help patients with peripheral artery disease

hotspot

fashion

knowledge

Medicare details structure of new drug price negotiation program

Cord blood banking comes at a high cost to babies

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

See how much Covid

How to save PrEP access — and even expand it

WuXi Biologics beefs up its lobbying operation

Trump demands the U.S. pay no more for drugs than other countries … again

With trial win, GSK could get blood cancer drug back on market

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Woman returns to dialysis after doctors remove transplanted pig kidney

hotspot

Supreme Court to hear if Covid misinformation is protected speech

Abbott's new stent may help patients with peripheral artery disease

As H5N1 spreads in cows, experts warn against drinking raw milk

Let's speed up science by embracing open access publishing

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

hotspot

entertainment

explore

Wikipedia